Brief: Puma Biotechnology Presents Updates From The Summit Trial At The 2021 Sabcs Annual Meeting

Puma Biotechnology

10/12/2021 18:03

Dec 10 (Reuters) - Puma Biotechnology Inc  PBYI.O :
    * PUMA BIOTECHNOLOGY PRESENTS UPDATES FROM THE SUMMIT TRIAL
AT THE
2021 SABCS ANNUAL MEETING
    * PUMA BIOTECHNOLOGY - NERATINIB  WITH TRASTUZUMAB RESULTS
IN
STRONG ACTIVITY IN PATIENTS WITH TRIPLE NEGATIVE METASTATIC
BREAST CANCER WITH HER2 MUTATION

Source text for Eikon:  urn:newsml:reuters.com:*:nBw9jbD22a
Further company coverage:  PBYI.O 

 ((Reuters.Briefs@thomsonreuters.com;))